Fluorescence in situ hybridization (FISH) is a powerful tool for detection of numerical and structural chromosomal aberrations. We have compared conventional banding techniques and FISH for the detection of monosomy 7 ( -7) and trisomy 8 ( + 8) in 89 patients with myeloid malignancies. Of these patients, 21 had -7,30 had + 8, four had both, and 34 had no aberrations or aberrations other than -7 or + 8 as assessed by banding techniques. Sequential samples were available in 23 patients. Alphoid DNA probes specific for chromosomes no. 7 and 8 were used for FISH. As controls, 10 normal bone marrow (BM) samples were hybridized with the chromosomes no. 7 and 8 probes, and in addition all tumor samples were hybridized with a chromosome no. 1 specific probe. The cut-off value for -7 was 18% one-spot cells, and for + 8 was 3%
M ized by specific numerical or structural chromosoma1 abnormalities that have prognostic, therapeutic, and biologic implications.'.' Two of the most common numerical aberrations in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are monosomy 7 (-7) and trisomy 8 (+8). These and other chromosomal aberrations can be detected by banding and fluorescence in situ hybridization (FISH) techniques, both having their own specific advantages and disadvantages.
For banding techniques, metaphase cells must be obtained and the metaphase cells harvested must have a certain quality for proper banding and evaluation. As the metaphase cells are only a small subset of the cells present in the cell suspension, the qualitative and quantitative potentialities of banding techniques may be limited. In addition, the quality constraint may contribute to biased qualitative and quantitative analysis. Recent developments in DNA in situ hybridization probes and protocols, in particular FISH, have made this technique widely available for cytogenetic research and diagnostic^.^-^ The molecular in situ hybridiza-0 1993 by The American Society of Hematology.
tion approach can supplement morphologic banding analysis in several ways: (1) marker chromosomes can be identified, that is, the morphologic identification can be validated7,*; (2) breakpoints caused by deletions, inversions, or translocations can be delineated more preci~ely;~*'~ (3) metaphase cells of poor quality or those obtained from archival material can be analyzed; and (4) interphase cells can be studied (interphase cytogenetics), hence the in vivo occurrence of chromosomal aberrations can be assessed and quantified. Only a few reports have been published on the benefit of FISH versus banding cytogenetic analysis in large series of patients. For example, Jenkins et all' examined material of 60 patients with +8, 13 with nonclonal +8, and 144 with normal karyotypes or aberrations other than +8.
In our study, banding and in situ hybridization cytogenetics were compared, both qualitatively and quantitatively, on bone marrow (BM) or peripheral blood (PB) cells of 5 5 patients with myeloid malignancies and -7 or +8 identified by banding techniques. Furthermore, material obtained from 34 patients who had normal karyotypes or aberrations other than -7 or +8 was also studied.
MATERIALS AND METHODS
Patients. BM or PB cells of 55 patients with myeloid malignancies, mostly AML and MDS, and -7 or +8 as assessed by banding analysis, were available for in situ hybridization studies. This included patients with nonclonal abnormalities according to the specifications of the Standing Committee on Human Cytogenetic Nomenclature (ISCN)." Cell suspensions were stored for up to 4 years before in situ hybridization was performed. Data of nine patients -7 AND +8 DETECTION BY FISH 905 mitotic arrest from BM and PB, either directly or after 24-, 48-, and 72-hours cultures, hereafter referred to respectively as BMD, PBD, BM24, PB24, etc. Cells were harvested and processed according to standard techniques, after which GTG-banding was perf~rmed.'~ If possible, at least 20 metaphases were analyzed, and five metaphases were fully karyotyped. Karyotyping was performed following ISCN specifications.12 Samples were classified as -7 if at least three metaphases were found with a deleted chromosome no. 7. Trisomy 8 was diagnosed if at least two metaphases were found with an extra chromosome no. 8. If these criteria were not met, the sample was classified as nonclonal -7 or +8.
FISH. FISH was performed on BM and PB cell suspensions that had been used for banding analysis stored in methano1:acetic acid (3: 1 vol/vol) at -20°C or +4"C. Also, BM aspirates (BMA), used for cytologic diagnosis and obtained simultaneously with the samples used for banding, were fixed and stored for FISH studies. Alphoid repetitive DNA sequences specific for chromosomes no. 7 (p7tl for locus D7Z1)I5 and 8 (ATCC, D8Zl)," hereafter referred to as ap7 and ap8, respectively, were used as probes. As a control probe, satellite DNA specific for the lq12 heterochromatic region (PUC1.77) was used.I6 In some cases, additional hybridizations with chromosome-specific libraries were performed." Fixation of cells, preparation of slides, predigestion of cells, hybridization conditions, posthybridization washings, and immunodetection were all performed according to standard protocols as previously deVisualization of the hybridization reactions was done by fluorescein isothiocyanate (FITC). Hybridization signals were evaluated on a LEITZ Diaplan fluorescence microscope (Emst Leitz Wetzlar GmbH, Germany) equipped with a K3 filter for simultaneous detection of FITC signals and propidiumiodide (PI) DNA counterstaining. All slides were analyzed by at least two observers. From each preparation, 200 interphase nuclei and all available metaphases present on one slide were evaluated. As the differences between the observers varied in general between 0% and lo%, the results were summed and averaged.
RESULTS

Controls
. Two types of controls were used for determination of the cut-off values for detection of -7 and +8: (1) the test probes specific for chromosomes no. 7 and 8 were hybridized onto control BM cells with normal karyotypes, and (2) the tumor cells were hybridized with a control probe specific for chromosome no. 1 [N = 82, samples with structural or numerical abnormalities of chromosome no. 1, eg, +t( 1;7) or +t( 1;9) were excluded]. The first type of control gave an estimation of the specificity of the test probes, and the second control provided an estimation of the overall hybridization quality of the test material.
The results of the control studies are listed in Table 1 . For detection of -7, the control samples showed a cut-off level of 1 1.7% (mean + 2 SD), and the control probe showed a cut-off level of 17.7%. Therefore, a threshold value of 2 18% was used for detection of -7. To distinguish true -7 from suboptimal hybridization, all samples with more than 15% null spot cells were rehybridized with prolonged predigestion times; if the results did not improve, these data were discarded. For detection of +8, the studies of the control samples and control probe showed cut-off levels of 2. I % and 2.9%, respectively. Therefore, a threshold of 23% was used for detection of +8 by interphase in situ hybridization.
Detection of -7 and +8 with FISH. Clinical and cytogenetic data from the -7 and +8 patients are listed in Tables 2 Abbreviations: ap7, alphoid DNA probe specific for chromosome 7; ap8, alphoid DNA probe specific for chromosome 8; BMT, bone marrow transplantation; spl. satellite DNA probe specific for chromosome 1. and 3, respectively. Twenty-one patients had -7 (clonal or nonclonal), 30 had +8 (clonal or nonclonal), and four had combined -7 and +8 (no. 22 through 25 in Table 2 , and no. 31 through 34 in Table 3 ). Sequential samples were available in 23 patients. In four samples with +8, parallel BMD and BMA specimens processed separately in different laboratories demonstrated similar percentages of three-spot interphase cells (Table 3 , patients no. 4, 14, and 19). These results corroborate the reliability of FISH procedures, both for the detection of low and high percentages of +8 cells.
In 51 of 55 patients, FISH confirmed the presence of -7 or +8 as detected by banding (Fig 1) . The following four patients showed a discongruency between banding and FISH: (1) patient no. 5 of the -7 group showed 1 I of 11 metaphases with a -7 and three marker chromosomes by banding (PB, there was no material left for FISH); the parallel BM culture showed five of five metaphases with two spots, and no significant number of one-spot interphase cells by FISH (no assessable metaphases in the banding analysis). Most probably, the marker chromosomes contained chromosome no. 7 DNA (no material left for chromosome painting). (2) Patient no. 7 had a complex karyotype with a t( l;?) and multiple markers. Chromosome painting showed multiple fragments of chromosomes no. 1 and 7 in metaphase cells without a t ( 1;7).9 (3) Patient no. IO had a -7 and an additional t(7;16) in I 1 of 12 metaphases. FISH with the ap7 probe did not show a significant increase of one-spot cells. Chromosome painting demonstrated the presence of one complete and one partial chromosome no. 7 (Fig 2) . (4) Patient no. 1 1 of the +8 group had 26 of 29 metaphases with a +8. FISH with the ap8 probe and with a chromosome no. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) were classified according to the subdivisions of the French American British (FAB) cooperative g r o~p .~~.~~ It was not possible to subclassify all individual samples, in these cases the diagnosis MDS or AML NOS was used.
8-specific library could not demonstrate any additional
Abbreviations: RA, refractory anemia; RARS. RA with ringed sideroblasts; RAEB, RA with excess of blasts; RAEB-t, RAEB in transformation; CMML, chronic myelomonocytic leukemia; BMA, bone marrow aspirate; BMD. bone marrow direct culture; BM24.24-hour culture, etc; ND, not done; NE, not evaluable; a.0.. among others; PB, peripheral blood; PBD, peripheral blood direct culture; PB24, 24-hour culture, etc.
Number of aberrant metaphases versus total of metaphases analyzed.
t Peripheral blood samples were cultured with phytohemagglutinin. t Highly abnormal metaphases.
chromosome no. 8 DNA. Therefore, the identification of the extra chromosome with standard GTG-banding was not correct. Material of 34 AML or MDS patients with aberrations other than -7 or +8 was investigated by FISH. Twenty-five had normal karyotypes as assessed by banding analysis. In 33 patients, at least 20 metaphases and in one patient six metaphases were karyotyped (data not shown). Using the criteria outlined above, a -7 or +8 was not found in any of the samples using interphase cytogenetics. The average number of cells with one spot using the ap7 probe was 4.8 (maximum, 16; minimum, 0; SD = 3.44), and the average number of cells with three spots using the ap8 probe was 0.8 1 (maximum, 2.5; minimum, 0; SD = 0.81). (Fig 3A) and 10 samples could be compared for banding versus interphase FISH (Fig 3B) . All samples but one had a clonal -7 according to the ISCN criteria. A good correlation between metaphase FISH and interphase FISH was found (Y = 37). Comparison of interphase FISH with banding corroborated the presence of a -7 clone, but did not show any quantitative relation (Fig 3B) .
In the +8 group, 28 samples could be compared for metaphase and interphase FISH (Fig 4A) and 26 samples for banding versus interphase FISH (Fig 4B) . The FISH metaphase analysis included six samples with a nonclonal +8. A high correlation ( r = .89) between metaphase FISH versus interphase FISH was found. In contrast to the -7 study, a high correlation between banding and interphase FISH was also found ( r = .93). Nine samples had a nonclonal +8 in the banding analysis; in these samples, 3% to 10% three-spot interphase cells were found.
To obtain further insight into the quantitative aspects of banding and FISH on metaphase cells of patients with clonal abnormalities, we extracted relevant data from Tables 2 and 3 (Table 4) . Samples with fewer than 10 assessable metaphase cells were also included, but grouped separately. Although, in contrast to banding, FISH was performed on only one slide, generally more metaphase cells could be evaluated by FISH than by banding. This emphasizes the practical significance of FISH. Using a 25% difference as a criterion, the clone size as estimated by FISH analysis of metaphases was smaller than as assessed by banding in approximately half of the -7 samples (Table 4) . In case of +8, no gross differences were found between both techniques. The data showed that the discrepancies for -7 were relatively independent of the total numbers of cells analyzed, ie, they apparently were not caused by quantitative inaccuracies.
We investigated whether it was possible to detect a clone of aberrant cells with FISH in cases with nonclonal (by ISCN criteria) -7 or +8. Samples with inconclusive banding analysis, eg, two of two aberrant metaphases, were also included. Seven samples of the -7 group ( 2, 4 , and 23 demonstrated 29%, 82%, 55%, and 78% one-spot cells, respectively, also indicative of -7 clones. The presence of these -7 clones was confirmed by banding of other samples of the same patients.
In three patients (no. 3, 24, and 25), no -7 clone was found by FISH. Follow-up of patient no. 3 showed intravascular hemolytic anemia due to a heart valve prosthesis, in-FISH analysis of nonclonal samples.
stead of myeloid malignancy. Banding analysis of patient no. 24 showed one metaphase with a complex karyotype including -7, +8, and marker chromosomes in the PB24, while the PB48 was not assessable. No PB24 cells were left for FISH, and a -7 clone could not be detected in the PB48. This leaves several possibilities: the metaphase with -7 was an artifact, the aberrant clone was lost during the prolonged culture, or the two spots per cell in 87% of the cells resulted from one chromosome no. 7 and one marker chromosome. Patient no. 25 had two of 15 metaphases with 5q-, -7, and one marker chromosome. No increase of -7 interphase cells was detected by FISH, but metaphase analysis suggested a clonal aberration (3/15 one-spot cells). However, these FISH data are difficult to interpret, especially since the chromosome no. 1 control probe showed 2 1% of interphase cells with one spot, indicating suboptimal hybridization properties of the material.
The first 10 +8 patients listed in Table 3 had one or more samples with a nonclonal +8. Four of them have been reported previously (no. 4, 6, 7, and 10).9,'3 In the first nine patients, FISH demonstrated 3% to 14% three-spot interphase cells, indicating that the samples contained small populations of +8 cells. Note that other samples of these patients did not show +8 by banding, but consistently demonstrated a significant proportion of +8 cells as assessed by FISH. Patient no. 10 had +8 in one of five cells analyzed by banding, but 43% three-spot interphase cells. The high number of three-spot cells with the chromosome no. 1 control probe was caused by a +t( 1;7).9
To determine the biologic significance of the quantitative differences between banding and interphase cytogenetics, we compared all available samples, especially the follow-up samples of several patients. (1) The BMD of patient no. 6 of the -7 group had 14 of 14 aberrant metaphases, but no -7 interphase clone was observed in the same sample cultured for 24 hours (no BMD cells available for FISH). However, a BMA taken 14 months later showed 64% one-spot cells. The negative FISH results in the first BM24 sample might have been caused by selective loss of the aberrant myeloid cells during culture, or by interchange of patient samples. ( 2) The PB sample of patient no. 8 of the -7 group had 14 of 14 metaphases with -7 by banding, two of three one-spot cells by metaphase FISH, but only 10% one-spot interphase cells. This discrepancy might be explained by the presence of 66% nondividing lymphoid cells (differential not shown) in the PB sample. We, and others, have shown that these genetic alterations in myeloid malignancies are restricted to the myeloid c~m p a r t m e n t . '~-~~ Taking into consideration the aforementioned cut-off value of 18% for one-spot cells, it would be impossible to detect a -7 clone in interphase cells of this sample. (3) Patient no. 9 of the -7 group had 20 of 20 metaphases with -7, whereas FISH showed 15 of 16 onespot metaphase and 15% one-spot interphase cells. This discrepancy cannot be explained (no follow-up available). (4) The data of patient no. 22 of the -7 group suggest that with FISH metaphase analysis the -7 clone could have been detected 6 months before it was found by banding analysis. In the second sample, the clone size as measured by interphase
Quantitative discrepancies: Selected cases.
For PB24 (414) BM24 (1 311 6) BM24 (-) BMD (24129) BMD (23128) 8M24 (6120) BM24 (211 6) PB24 (010)
PB48 (411 8 Table 2. 11 BM cells were deep frozen, thawed, and cultured for 4 days stimulated with granulocyte-monocyte colony-stimulating factor (GM89-107, Sandoz). hybridized with the chromosome no. 7-specific library. One complete chromosome no. 7 and one partial chromosome no. 7 is seen. The latter is derived from the +t(7;16) and caused a normal distribution of spots per cell using the up7 probe with 97% two-spot cells and 3% one-spot cells.
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DISCUSSION
In this study, banding and FISH cytogenetics of -7 and +8 in were compared qualitatively and quantitatively in a large series of patients with myeloid malignancies. Several features, including advantages and disadvantages of the FISH methodology, are demonstrated.
A critical problem in interphase FISH methodology is determination of the cut-off values for establishing the diagnosis of aberrant clones. This is important for quantitative applications, eg, the detection of minimal residual disease or early relapse. Due to variables related to the quality of cells, probe features, hybridization conditions, immunoreagents, and observers, FISH will result in a certain number of cells of which the true number of targets (chromosomes) is not properly assessed. This problem is especially relevant for determination of loss of chromosomes. Under optimal conditions, FISH applied to normal diploid cells will result in values of 5% to 10% one-spot cells (Table 1) . We have developed two types of controls for determination of the cut-off values for -7 and +8 detection: (1) normal cells hybridized with the test probes specific for the test chromosomes no. 7 and 8, and (2) a control probe for which the tumor cells were assumed to be disomic, hybridized onto the test samples. Cut-off values were determined by calculation of the mean + 2 SD for one-spot cells and three-spot cells, respectively. This procedure resulted in a 18% onespot cell value for -7 detection, and a 3% three-spot cell value for +8 detection. The relative high -7 cut-off level is caused in part by the chromosome no. 1 data obtained from the test cells. However, this high level may be too conservative, in particular as nonrandom loss of chromosome no. I in the test cells cannot be excluded. For trisomy detection, a cut-off value of 3% was established, which is similar to the value reported by Jenkins et al.'' The similar results obtained from parallel BMAs and directly cultured cells validate the conclusion that values as low as 3% cannot be attributed to technique variables.
The main advantage of FISH is the possibility to quantitate aberrant cells. Both in the -7 and the +8 group, we found that by applying the FISH methodology the relative numbers of aberrant metaphase cells were proportional to the relative numbers of interphase cells (Figs 3A and 4A) .
This indicates that the percentage of aberrant cells in mitosis is representative for the in vivo clone size, and that there is no mitotic selection. Interestingly, the same was found for banding versus FISH interphase analysis of +8 (Fig 4B) , but not for -7. Banding analysis generally resulted in higher proportions of -7 cells compared with FISH (Fig 3B and  Table 4 ). This may be explained by positive observer bias in the banding analysis, which is understandable as -7 metaphases are often difficult to evaluate.
We have tried to determine the biologic significance of nonclonal abnormalities as defined by the ISCN criteOne major handicap of the ISCN criteria is that no minimum number of analyzed metaphases is required. In our study, we regarded IO metaphases as a minimum for quantitative analysis, but we also included samples with lower numbers for qualitative evaluation. Interphase FISH proved its value especially, but not exclusively, in those cases with few assessable metaphase cells. Thus, four of seven samples with a nonclonal -7 had significantly increased numbers of -7 cells by FISH. In the +8 group, all but one sample demonstrated significant increases of threespot cells (3% to 25%). In most cases, these elevations centered just above the threshold value of 3%. Jenkins et all' found similar small increases in four of 13 nonclonal +8 patients.
FISH analysis of our 34 patients with normal karyotypes or aberrations other than -7 or +8 as assessed by banding analysis showed no percentages of aberrant cells above the stipulated thresholds. This validates the reliability of the banding procedures, and provides additional evidence that levels as low as 3% trisomic cells reflect biologic phenomena and not artifacts. Using a similar approach in a series of 144 ria. 12,24,25
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From patients with a myeloid malignancy without +8, Jenkins et all' reported an increase of three-spot interphase cells by FISH in seven patients. The percentages of these three-spot cells were low (2.7% to 3.4%). Interestingly, a comparable problem concerning low percentages of aberrant cells was observed in our study on trisomy 12 in chronic lymphocytic leukemia.26 A considerable part of the patients had 3% to 5% of cells with three spots. The biologic and clinical significance of these low percentages of aberrant cells as determined by FISH is not known.
Several of our -7 and +8 samples demonstrated two potential pitfalls in interphase cytogenetics: ( l ) admixture with nontumor cells ( Table 2 , patient no. 8). We and others have shown that lymphoid cells do not contain the here studied genetic aberrations -7 and +8.'8-22 The same is reported for the +t( 1;7),2' and for 5q deletion^.'^ In view ofthe relatively high threshold value for monosomy detection, it would have been almost impossible to make an -7 interphase diagnosis in the sample of patient no. 8. (2) This and other studies demonstrated that the presence of translocations or marker chromosomes can lead to misinterpretations of (FISH) spots per cell distrib~tions.~,~,'~ For example, patient no. 10 of the -7 group had I 1 of 12 -7 metaphase cells in the banding analysis, but due to an additional t(7;16), the -7 could not be detected with the ap7 probe.
In conclusion, this study has shown the feasibility and potential of FISH analysis in a large series of MDS and AML patients. FISH may be more sensitive than conventional cytogenetics, especially in samples with nonclonal abnormalities and with few or poorly assessable metaphases. However, the potential of FISH must not be overestimated, which was illustrated by the fact that we did not identify any additional case of (low percentage) -7 or +8 in 34 patients without a -7 or +8 established by banding. Moreover, the threshold for -7 was relatively high. As FISH will be used more and more in cytogenetic diagnosis, follow-up, and therapy m~nitoring,'~ it will be necessary to standardize FISH procedures and supplement the ISCN definitions of a clone with criteria specifically for FISH.
